Triggering receptor expressed on myeloid cells (TREM) family and the application of its antagonists

Recent Patents on Anti-Infective Drug Discovery

Volumn 4, Issue 1, 2009, Pages 51-56

  Molloy, Elcanor J ^a,b,c  

^a NATIONAL MATERNITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Myeloid cell; Sepsis; Toll like receptor

Indexed keywords

ANTIBIOTIC AGENT; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; SOLUBLE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TOLL LIKE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 MONOCLONAL ANTIBODY; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 MONOCLONAL ANTIBODY; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 4; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM1 PROTEIN, HUMAN; TREM2 PROTEIN, HUMAN;

BACTERIAL IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; ENDOTOXEMIA; HUMAN; IMMUNOMODULATION; INFECTION SENSITIVITY; INNATE IMMUNITY; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PATENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VACCINE PRODUCTION; ANIMAL; DRUG ANTAGONISM; PHYSIOLOGY;

ANIMALS; HUMANS; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC;

EID: 62749164849     PISSN: 1574891X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489109787236292     Document Type: Review

References (46)

1. Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: Secondary analysis of a high quality clinical database, the ICNARC case mix programme database. Crit Care 2006; 10(2): R42.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35: 1244-1250.
3. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
4. Marshall JC.The International Sepsis Forum's controversies in sepsis: How will sepsis be treated in 2051? Crit Care 2002; 6(6): 465-467.
5. Russell JA. Management of sepsis. N Engl J Med 2006; 355(16): 1699-1713.
6. Allcock RJ, Barrow AD, Forbes S, Beck S, Trowsdale J. The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol 2003; 33: 567-577.
7. Schmausser B, Endrich S, Beier D, et al. Triggering receptor expressed on myeloid cells-1 (TREM-1) expression on gastric epithelium: Implication for a role of TREM-1 in Helicobacter pylori infection. Clin Exp Immunol 2008; 152(1): 88-94.
8. Chen LC, Laskin JD, Gordon MK, Laskin DL. Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp Mol Pathol 2007; 84: 145-155.
9. Cantoni C, Bottino C, Vitale M, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 1999; 189(5): 787-796.
10. Klesney-Tait J, Colonna M. Uncovering the TREM-1-TLR connection. Am J Physiol Lung Cell Mol Physiol 2007; 293(6): L1374-1376.
11. Tessarz AS, Cerwenka A. The TREM-1/DAP12 pathway. Immunol Lett 2008; 116(2): 111-116.
12. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359-93.
13. Dietrich J, Cella M, Seiffert M, Bühring HJ, Colonna M. Cutting edge: Signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells. J Immunol 2000; 164(1): 9-12.
14. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164: 4991-4995.
15. Colonna M, Facchetti F.TREM-1 (triggering receptor expressed on myeloid cells): A new player in acute inflammatory responses. J Infect Dis 2003; 187: S397-401
16. Gingras MC, Lapillonne H, Margolin JF. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol 2002; 38(11): 817-824.
17. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410: 1103-1107.
18. Bleharski JR, Kiessler V, Buonsanti C, et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 2003; 170(7): 3812-818.
19. Radsak MP, Salih HR, Rammensee HG, Schild H. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: Differential regulation of activation and survival. J Immunol 2004; 172: 4956-4963.
20. Knapp S, Gibot S, de Vos A, Versteeg HH, Colonna M, van der Poll T. Cutting edge: Expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol 2004; 173(12): 7131-7134.
21. Ornatowska M, Azim AC, Wang X, et al. Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol 2007; 293(6): L1377-84.
22. Fortin CF, Lesur O, Fulop T Jr. Effects of TREM-1 activation in human neutrophils: Activation of signaling pathways, recruitment into lipid rafts and association with TLR4. Int Immunol. 2007; 19(1): 41-50.
23. Wong-Baeza I, González-Roldán N, Ferat-Osorio E, et al. Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin Exp Immunol 2006; 145(3): 448-455.
24. Sharif O, Knapp S. From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infectionImmunobiology 2008; 213(9-10): 701-713
25. Kondo T, Takahashi K, Kohara N, et al. Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): Three genetic forms. Neurology 2002; 59(7): 1105-1107.
26. Humphrey MB, Daws MR, Spusta SC, et al. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J Bone Miner Res 200; 21(2): 237-245.
27. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005; 201(4): 647-657.
28. Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL. Cutting edge: Inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 2006; 177(4): 2051-2055.
29. Colonna, M., Panina, P.: US20060263770 (2006).
30. Gibot S, Kolopp-Sarda MN, Bene MC, et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 2004; 200: 1419-1426.
31. Gibot S, Kolopp-Sarda MN, Bene MC, et al. Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004; 141(1): 9-15.
32. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004; 350: 451-458.
33. Gómez-Piña V, Soares-Schanoski A, Rodríguez-Rojas A, et al. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 2007; 179(6): 4065-4073.
34. Gibot S, Cravoisy A. Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection Clin Med Res 2004; 2(3): 181-187
35. Chen HL, Hung CH, Tseng HI, Yang RC. Soluble form of triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic marker of serious bacterial infection in febrile infants less than three months of age. Jpn J Infect Dis 2008; 61(1): 31-35.
36. Colonna, C., Bouchon, A.: US20030165875 (2003).
37. Faure, G., Gibot, S., Panina, P., Passini, N.: US20060246082 (2006).
38. Kuai, J., Dower, K., Feldman, J.L., Pittman, D.D., Chaterjee-Kishore, M.: US20080247955 (2008).
39. Colonna, M., Bouchon, A.: US20050260670 (2005).
40. Gringas, M.C., Margolin, J.F.: US20020128444 (2002).
41. Gingras, M.C., Margolin, J.F.: US20050180973 (2005).
42. Colonna, M., Panina, P., Thomas, N.C.: PCTGB2003001231 (2003).
43. Mori, T., McVicar, D.W., Giomarelli, B., Washington, A.V.: US 20080131423 (2008).
44. McVicar, D., Washington, A.V., Quigley, L.: US20040180409 (2004).
45. Kolopp-Sarda, M.N., Bene, M.C., Panina, P., Di Lucia, P., Levy, B., Bollaert, P.E., Faure, G., Gibot, S.: US20070281319 (2007).
46. Mariani, M., Sinigaglia, F., Panina, P.: US20060183125 (2006).